China Universal Asset Management Co. Ltd. Raises Holdings in AbCellera Biologics Inc. (NASDAQ:ABCL)

China Universal Asset Management Co. Ltd. grew its position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 352.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 33,566 shares of the company’s stock after buying an additional 26,143 shares during the […]

Related Keywords

China ,Stifel Nicolaus ,Eli Lilly ,Abcellera Biologics ,Pacifica Partners Inc ,Nasdaq ,Exchange Commission ,China Universal Asset Management Co ,Belpointe Asset Management ,Worth Asset Management ,Abcellera Biologics Inc ,China Universal Asset Management ,Free Report ,Universal Asset Management ,Asset Management ,Cellera Biologics Stock Down ,Cellera Biologics ,Get Free Report ,Cellera Biologics Inc ,Confo Therapeutics ,Visit Holdingschannel ,Abcellera Biologics Daily ,